Arpha Oai Pmh Endpointmetadata only
Cost-effectiveness of continuous vs. treatment-free remission strategies in chronic myeloid leukemia: a Markov modeling study from a single center in Bulgaria
chronic myeloid leukemia, national health insurance fund, pharmacoeconomic cost-utility analysis, pharmacoeconomics, remission without treatment, targeted therapy, tyrosine kinase inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 397917
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.